Active-ingredient Dossier
Pomalidomide
Active-ingredient Dossier for Pomalidomide (immunomodulatory agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: POMOLIDE
- Brand: POMALYST
- Brand: POMALIDOMIDE SANDOZ
- Brand: POMALIDOMIDE
- Brand: POMALIDOMIDE
- Brand: POMALIMED
- Therapeutic area: Oncology
- Therapeutic area: Haematology
What is
Pomalidomide Pomalidomide is an immunomodulatory agent.
Australian brands containing
Pomalidomide — POMOLIDE — POMALYST — POMALIDOMIDE SANDOZ — POMALIMED
Therapeutic areas
Pomalidomide is registered in oncology, with six brands containing the ingredient available on the ARTG.
Sponsor landscape
The ingredient is marketed by four sponsors: Medsurge Pharma, Juno Pharmaceuticals, Sandoz, and Bristol-Myers Squibb.
PBS and regulatory activity
One brand containing pomalidomide has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 July 2023, with three brands holding PBAC outcomes on record.